Page 5 - Scottish Medicines Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AbbVie s oral therapy Aquipta recommended by NICE for migraine prevention in adults

AbbVie s oral therapy Aquipta recommended by NICE for migraine prevention in adults
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Helen knightRachael millwardAbbvie aquiptaNational institute for healthNational instituteCare excellenceScottish medicines consortiumAbbvie united kingdom

New pill to give migraine relief to 170,000 people in England

New pill to give migraine relief to 170,000 people in England
plymouthherald.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plymouthherald.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomAndrew stephensonHelen knightRachael millwardNational institute for healthScottish medicines consortiumNational instituteCare excellenceMigraine trustRob musicAbbvie united kingdom

Axis Consulting looks to double headcount as demand surges for new drug evaluations

The Dublin-based firm assists pharmaceutical companies with the regulatory scrutiny drugs must endure to get onto the market

United kingdomCity ofBrenda dooleyNational centre for pharmacoeconomicsNational institute for healthScottish medicines consortiumAxis consulting picturePaul sherwood photographyAxis consultingNational centreNational instituteCare excellenceBecausei m

Migraine pill to widen treatment options for 170,000 sufferers

Atogepant has been given the green light for NHS use in England by the National Institute for Health and Care Excellence.

United kingdomAndrew stephensonRachael millwardHelen knightNational institute for healthScottish medicines consortiumNational instituteCare excellenceMigraine trustRob musicAbbvie united kingdom

Life-changing once-a-day migraine pill which halves the number of crippling attacks gets green light for NHS use

The pill - sold under the brand name Aquipta and made by pharmaceutical company AbbVie - could be a blessing for some 170,000 sufferers in England.

United kingdomRachael millwardHelen knightAndrew stephensonPeter goadsbyKing college hospitalNational institute for healthScottish medicines consortiumNational instituteCare excellenceCollege hospitalMigraine trustRob musicMinister andrew stephensonAbbvie united kingdom